Intervention Review

You have full text access to this OnlineOpen article

Interventions to improve professional adherence to guidelines for prevention of device-related infections

  1. Gerd Flodgren1,*,
  2. Lucieni O Conterno2,
  3. Alain Mayhew3,
  4. Omar Omar4,
  5. Cresio Romeu Pereira5,
  6. Sasha Shepperd1

Editorial Group: Cochrane Effective Practice and Organisation of Care Group

Published Online: 28 MAR 2013

Assessed as up-to-date: 16 JUL 2012

DOI: 10.1002/14651858.CD006559.pub2

How to Cite

Flodgren G, Conterno LO, Mayhew A, Omar O, Pereira CR, Shepperd S. Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD006559. DOI: 10.1002/14651858.CD006559.pub2.

Author Information

  1. 1

    University of Oxford, Department of Public Health, Oxford, Oxfordshire, UK

  2. 2

    Marilia Medical School, Department of General Internal Medicine and Clinical Epidemiology Unit, Marilia, São Paulo, Brazil

  3. 3

    Ottawa Hospital Research Institute, The Ottawa Hospital - General Campus, Centre for Practice-Changing Research, Ottawa, Ontario, Canada

  4. 4

    Centre for Statistics in Medicine, Oxford, UK

  5. 5

    Municipal Health Department, Infection Control, Ilhabela, SP, Brazil

*Gerd Flodgren, Department of Public Health, University of Oxford, Rosemary Rue Building, Old Road Campus, Headington, Oxford, Oxfordshire, OX3 7LF, UK. gerd.flodgren@dph.ox.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 28 MAR 2013

SEARCH

[Figure 1]
Figure 1. Study flow diagram.
[Figure 2]
Figure 2. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Ventilator-associated pneumonia (VAP) analysis, Outcome 1 VAP change in pre- and post-intervention slope at 3 to 6 months.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Ventilator-associated pneumonia (VAP) analysis, Outcome 2 VAP 3 months level.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Ventilator-associated pneumonia (VAP) analysis, Outcome 3 VAP 6 months level.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Ventilator-associated pneumonia (VAP) analysis, Outcome 4 VAP 9 months level.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Ventilator-associated pneumonia (VAP) analysis, Outcome 5 VAP 12 months level.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 1 CLABSI change in pre- and post-intervention slope at 4 to 8 months.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 2 CLABSI 3 months level.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 3 CLABSI 6 months level.
[Analysis 2.4]
Analysis 2.4. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 4 CLABSI 9 months level.
[Analysis 2.5]
Analysis 2.5. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 5 CLABSI 12 months level.
[Analysis 2.6]
Analysis 2.6. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 6 CLABSI 18 months level.
[Analysis 2.7]
Analysis 2.7. Comparison 2 Central line-associated blood stream infections (CLABSIs) analysis, Outcome 7 CLABSI 21 months level.